PATHEON N.V. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -.--% |
| 2017 | Patheon : Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services | RE |
| 2017 | Patheon : Thermo Fisher to buy Patheon for $5.2 billion to expand biopharma services | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 727B | ||||||
| 599B | ||||||
| 354B | ||||||
| 328B | ||||||
| 277B |
- Stock Market
- Equities
- PTHN Stock
- Charts Patheon N.V.
- Sector Chart
